UTHR - United Therapeutics Corporation
NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Alla chiusura: 04:00PM EDT
Dopo ore:
Il grafico dei titoli non è supportato dal tuo browser attuale
| Chiusura precedente | 217,22 |
| Aperto | 216,15 |
| Denaro | 0,00 x 1200 |
| Lettera | 0,00 x 800 |
| Min-Max giorno | 215,29 - 219,87 |
| Intervallo di 52 settimane | 201,65 - 283,09 |
| Volume | |
| Media Volume | 514.027 |
| Capitalizzazione | 10,256B |
| Beta (5 anni mensile) | 0,60 |
| Rapporto PE (ttm) | 14,25 |
| EPS (ttm) | 15,36 |
| Prossima data utili | 01 ago 2023 - 07 ago 2023 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 281,18 |
GlobeNewswire3D Systems Announces Formation of New Biotech Company, Systemic Bio™, to Accelerate Drug Discovery and Development
h-VIOS2 h-VIOS2 containing two perfused vascularized hydrogels. Within this chip’s footprint, any vasculature can be created. Taci Pereira Taci Pereira named CEO of Systemic Bio. New company will leverage 3D Systems’ recent breakthroughs in bioprinting of vascularized human organs and tissues to accelerate new drug development, reduce costs, and ultimately reduce or eliminate the need for animal testingUnique bioprinted organ-on-a-chip platform, h-VIOS™, created using hydrogels to produce comple
FX EmpireUnited Therapeutics Attracts Big Money
United Therapeutics Corporation (UTHR) stock has jumped this year, gaining 10% so far.